Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Highly potent and selective COX-2 inhibitors emerge from Glaxo Wellcome R&D

June 14, 2000

Japanese investigators isolate new type of antiinflammatory peptide

June 14, 2000

Isis and Elan joint venture moves ISIS-104838 towards clinical development

June 14, 2000

Japanese researchers discover new antiinflammatory substance

June 13, 2000

Cytokine production inhibitors described in patent literature by Novartis

June 13, 2000

CLX-1100: a novel antiinflammatory agent produced by a Himalayan plant

June 13, 2000

Cytokine production inhibitors developed by SB for inflammatory disorders

June 9, 2000

Orally active and selective COX-2 inhibitors described by Abbott

June 9, 2000

Preliminary pharmacological profile of NMI-377 presented at ASBMB/ASPET 2000

June 9, 2000

Rat studies demonstrate feasibility of AAV-TNFR:Fc gene therapy in rheumatoid arthritis

June 9, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...